Search research articles
Contact Us
Filters
Showing results (1121-1130 of 1,873) with videos related to
Page
of 188
Sort By:
JACC. Heart Failure
|
January 5, 2019
Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease
Iris E Beldhuis, Peder L Myhre, Brian Claggett, et al.
American Heart Journal
|
April 30, 2017
The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial
Carolyn Y Ho, John J V McMurray, Allison L Cirino, et al.
Journal of Cardiac Failure
|
December 1, 2025
Refining Atrial Shunt Therapy for HFpEF: Lessons from Pivotal Randomized Trials and Emerging Directions
Dylan J Gyberg, Jan Komtebedde, Uma Mylavarapu, et al.
JAMA Network Open
|
September 14, 2023
Temporal Association Among Influenza-Like Illness, Cardiovascular Events, and Vaccine Dose in Patients With High-Risk Cardiovascular Disease: Secondary Analysis of a Randomized Clinical Trial
Sheila M Hegde, Brian L Claggett, Jacob A Udell, et al.
Circulation. Heart Failure
|
June 22, 2019
Utility of the Cardiovascular Physical Examination and Impact of Spironolactone in Heart Failure With Preserved Ejection Fraction
Senthil Selvaraj, Brian Claggett, Sanjiv J Shah, et al.
European Journal of Heart Failure
|
May 16, 2023
Incremental prognostic value of biomarkers in PARADIGM-HF
Kirsty McDowell, Ross Campbell, Joanne Simpson, et al.
American Heart Journal
|
October 8, 2005
Prognostic use of echocardiography 1 year after a myocardial infarction
Hicham Skali, Leonardo A M Zornoff, Marc A Pfeffer, et al.
Journal of the American College of Cardiology
|
April 17, 2026
Interchangeability of the KCCQ-12 and KCCQ-23 Across >18,000 Participants Enrolled in 4 Large-Scale Trials of Heart Failure
Yasuhiro Hamatani, Brian L Claggett, Akshay S Desai, et al.
JACC. Basic to Translational Science
|
December 14, 2021
Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized Trial
Thorsten M Leucker, William O Osburn, Paula Reventun, et al.
Diabetes, Obesity & Metabolism
|
July 8, 2022
Re-examining the widespread policy of stopping sodium-glucose cotransporter-2 inhibitors during acute illness: A perspective based on the updated evidence
Kamlesh Khunti, Vanita R Aroda, Deepak L Bhatt, et al.
Page
of 188
Search research articles
Search
Showing results (1121-1130 of 1,873) with videos related to
Sort By:
Page
of 188
JACC. Heart Failure
|
January 5, 2019
Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease
Iris E Beldhuis, Peder L Myhre, Brian Claggett, et al.
American Heart Journal
|
April 30, 2017
The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial
Carolyn Y Ho, John J V McMurray, Allison L Cirino, et al.
Journal of Cardiac Failure
|
December 1, 2025
Refining Atrial Shunt Therapy for HFpEF: Lessons from Pivotal Randomized Trials and Emerging Directions
Dylan J Gyberg, Jan Komtebedde, Uma Mylavarapu, et al.
JAMA Network Open
|
September 14, 2023
Temporal Association Among Influenza-Like Illness, Cardiovascular Events, and Vaccine Dose in Patients With High-Risk Cardiovascular Disease: Secondary Analysis of a Randomized Clinical Trial
Sheila M Hegde, Brian L Claggett, Jacob A Udell, et al.
Circulation. Heart Failure
|
June 22, 2019
Utility of the Cardiovascular Physical Examination and Impact of Spironolactone in Heart Failure With Preserved Ejection Fraction
Senthil Selvaraj, Brian Claggett, Sanjiv J Shah, et al.
European Journal of Heart Failure
|
May 16, 2023
Incremental prognostic value of biomarkers in PARADIGM-HF
Kirsty McDowell, Ross Campbell, Joanne Simpson, et al.
American Heart Journal
|
October 8, 2005
Prognostic use of echocardiography 1 year after a myocardial infarction
Hicham Skali, Leonardo A M Zornoff, Marc A Pfeffer, et al.
Journal of the American College of Cardiology
|
April 17, 2026
Interchangeability of the KCCQ-12 and KCCQ-23 Across >18,000 Participants Enrolled in 4 Large-Scale Trials of Heart Failure
Yasuhiro Hamatani, Brian L Claggett, Akshay S Desai, et al.
JACC. Basic to Translational Science
|
December 14, 2021
Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized Trial
Thorsten M Leucker, William O Osburn, Paula Reventun, et al.
Diabetes, Obesity & Metabolism
|
July 8, 2022
Re-examining the widespread policy of stopping sodium-glucose cotransporter-2 inhibitors during acute illness: A perspective based on the updated evidence
Kamlesh Khunti, Vanita R Aroda, Deepak L Bhatt, et al.
Page
of 188